Local 12: UC startup gains approval for trials
Portable system from Sense Neuro Diagnostics can detect brain injuires
A startup founded by four University of Cincinnati physicians gained FDA approval to move forward with clinical trials for its portable system that can detect brain injuries, Local 12 reported.
Medtech startup Sense Neuro Diagnostics is developing the system, NeuSTAT, to help medical personnel diagnose everything from a traumatic brain injury in battle to a stroke.
“NeuSTAT is a device which will detect blood and for the trial, it’ll be approved to detect blood for someone who may have had a hemorrhagic stroke or bleeding from a traumatic brain injury,” Geoff Klass, CEO of Sense Neuro Diagnostics, said. “Worldwide, there's 50 billion traumatic brain injuries each year, and if you have a traumatic brain injury or if you have a stroke, immediate care is important.”
Sense Neuro Diagnostics hopes for results from the initial trial this year.
Featured image at top: Model of a brain. Photo by Robina Weermeijer on Unsplash
Innovation Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC studies: Silent mutations, tumor microenvironment may be therapeutic targets
April 17, 2026
University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2026 April 17 to 22 in San Diego.
New UC Blue Ash business officer is a familiar face on campus
April 17, 2026
Lacey McCarthy will bring her skills, expertise and more than 20 years of experience in budget and financing to her new role as business officer for the University of Cincinnati Blue Ash College.
UC experts present neurology research at national conference
April 17, 2026
University of Cincinnati researchers will present abstracts at the 2026 American Academy of Neurology Annual Meeting April 18 to 22 in Chicago.